Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

OBJECTIVE: To validate kappa free light chain (KFLC) and lambda free light chain (LFLC) indices as a diagnostic biomarker in multiple sclerosis (MS). METHODS: We performed a multicenter study including 745 patients from 18 centers (219 controls and 526 clinically isolated syndrome (CIS)/MS patients)...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mult Scler
Главные авторы: Leurs, CE, Twaalfhoven, HAM, Lissenberg-Witte, BI, van Pesch, V, Dujmovic, I, Drulovic, J, Castellazzi, M, Bellini, T, Pugliatti, M, Kuhle, J, Villar, LM, Alvarez-Cermeño, JC, Alvarez-Lafuente, R, Hegen, H, Deisenhammer, F, Walchhofer, LM, Thouvenot, E, Comabella, M, Montalban, X, Vécsei, L, Rajda, C, Galimberti, D, Scarpini, E, Altintas, A, Rejdak, K, Frederiksen, JL, Pihl-Jensen, G, Jensen, PEH, Khalil, M, Voortman, MM, Fazekas, F, Saiz, A, La Puma, D, Vercammen, M, Vanopdenbosch, L, Uitdehaag, BMJ, Killestein, J, Bridel, C, Teunissen, C
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2019
Предметы:
Original Research Papers
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350201/
https://ncbi.nlm.nih.gov/pubmed/31066634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458519845844
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы